INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138797, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f4552834b4c80000348c0551', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138798, 862, 3.5, 3.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc295130b45230d633cd4dd7cf4e57f00cd3f7f455283432c9280200668c078d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138799, 862, 4.5, 4.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc295130b25230d133cd4dd7cf4e57f00cd3f7f455283436d335b1c80000751707b9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138800, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f4552834b4c80000348c0551', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138801, 862, 3.5, 3.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc295130b45230d633cd4dd7cf4e57f00cd3f7f455283432c9280200668c078d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138802, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc295130b25230c94dd7cf4e57f00cd3f7f455283432d13536cb000069120750', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138803, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f45528543034ca00003980056b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138804, 862, 3.5, 3.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc295130b45230d633cd4dd7cf4e57f00cd3f7f455283432010057e406b3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138805, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc295130b25230c94dd7cf4e57f00cd3f7f455283432d13536cb000069120750', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138806, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f455283434ca00003480054b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138807, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230c94dd7cf4e57f00cd3f7f455283432c900004b970668', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138808, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4e5570ccc9b15230d233cd4dd7cf4e57f00cd3f7f455a8300400b3f709fe', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138809, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f4552834b4c80000348c0551', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138810, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230c94dd7cf4e57f00cd3f7f455283432d13536cb00005f5006fe', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138811, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f455283434ca00003480054b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138812, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230c94dd7cf4e57f00cd3f7f4552834320100452f0600', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138813, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f455283434ca00003480054b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138814, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230c94dd7cf4e57f00cd3f7f4552834b4c800004b9c066b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138815, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f45528b4c800002f790520', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138816, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230c94dd7cf4e57f00cd3f7f455283434ca00004b900665', X'789ced5a5b53db4816fe2ba778d825157c07c278b35365c88d4a202e9c64b21553aeb6d4963b48dddaee9613ed14ff7dbf966c631b19196576f330f39002a9fb7ce77e13f97dcfd74930922ce27b5dda7bcda56591f084dc3ba0bd4487eee5d4dad8741b8d6fe2864775a503f79b68acdf359e6631f747cc3a9276b37d5c6bb66aade687e6b3ee51a77bf4acde69b73b479dec2ef7ac50d2e0e6ef8e25d72ccc7eb7fc7b46fe218d7977287b91902a08534f19e1f3a17ca10c0b38bd523a325d3abff8079d7f1aca3315454ad207cd7c4e975004674e36e1a5f2805e33cda214421e642fd94d2640325e95e116af2c1b87dc3d7db9c65328e44df67027d3ba30e5e6d9b87f7bedb8f4fc24b423e82164b0a6712f0ca1d184d4981b7e4089e1d4f3bf26c6729f7ee322985afa279d9ffe464fa9593fa4efb4dfc343cdbd7a024339eafc3e691e7366c9cf78d0981920c03c219ff1d01428bf70c0a8bd26d0cbef964b1fb4e7d2723d63e1501ed59e4541e32680d5e9dfedc3e950be121a1ca10eefd2caa9f3899c391728e9081107f5c5e145c3519f4cf7d66dee8cf3517a2a8a43e131683d7aada4f294e76d8446fbb019391898a0558031809a9a8ffae72fd6a85af5a30dfe4339b04c5b6aafbe07a633a6ed52a7b64e90a97b2e270ab125669cbe098b171ee2c4cfc36b53969d626a83fee1803a5bb99c47d3cff3dc660cfde5ba47baae92c136adfea7b2d84f55b64ac3f8417dfbdc17cc6ae16d6d17ec070bfefef393d10b969ad1fbd07fb2067f571d28e3d45e1af953c385236cf9bc7d42df38bf3114706399431fca8d7bb96d33abafbf3f745e6a9fd4dabf9463b44e1ec0e8346b9dceee18d482ffefcba8f3c376970e370e3bc7b59ccfe11fc964e3a8d639762c8ef0b39c0bb5da0fb12961f22a0943fac07554207e7b61e74dd2a25ebd8ca17908d546add1859276faf840ea341f13045b8cb7631c6cd57147176fa1cfc4dbd1815b34c9a033f7d842f76c35c083de993b65543bce7f31ebeed9cae4f87efc3ec4e6d75de0efa06bcf8aeac44704899b70c5847e6da7ea113d26ef0f31f70484e9ab3809d95db55b08d3d73c904c7a295de1540643d9a51743f98e79b9a7bad4d76a0c06291936c1b671c53102515e7c21bb9bdcd7c72312f3016b5e7b71aacf426a356b47cd2e05ae99c0ad7901c94e9eb796ef0f4f6acf9cc7dff048a1ce87a911667eb63273b10918d0e27c2897a35d316764c1313808e9698e36b06809cbcb1bbd61215507346ca684efd68ea15c369e9db4ed6cd3b6eb0cd1fe65de559122b5cccbbb18a211732dac92dc315b374efb271ae60d8f1129de3c24b081b990a0bfd1d260d8c42e153a319f08c9fdaa73c366a0960f0f2fdc0a9f5f362321474b84f92801375acd3060b871f35e62a030731da46415792133a6e1be083c4ef8f96e8b01cdf0d11567de7d2ec5f3ab162a59bff7de2aabbe0b4fd87428bfb4ae61521e4ff5ca4ba469a8649069426a4292275a4589f190f69ac6a1f26e204741b9ca3f14ac71bb64f02c6bcc5424f29a70ae11793934662a21bfe6f29211963fba22fd8fd5db34e7ff5bbf3f82df2363ac3f653a621e2c14a46b8cdfb070520bc58477dbb50e4d55a291c5171c582a1426eaba1281e4cf0bfd478dfc24be78e12e7a532671cf19bce7e5b74e9130c66545a73920267d3ac24f2dc6caa8083503922752587380326474123b7d29babaec11724d9a70aeb49cd7a409820117dc768172e3e10d8a17c5f03c1730478aeec9b352f6a57d5d25f950a5c742a13c8d065cc2ba62867fbc3c07dff275430e86d220d838f401b786998371da4f4cc2c23045913b1fca4ca7282b7c389a31689375ce1552edf4b14c5a505c0de5f291f69526893ac927132709b0ddaa84da94a30f9e428414934580fb28b799c93c8ec9e81b6ec0a20b4d61ac8fb8ba947002dc8f1fce51c721c9be7451961acb23600839c99506fe670c9d5291cf2cc3437b28592e04dc009b697540e3c4660226ae2bdcc986db9d076edf5d5cd1ccc9f45aab24a61e198b558d6284702a03886c08874bc90cf90977e1f6b24e13c601e4a2e1f361158e734e281d4850c11e4e6cb49e4cc2ecfbaf6611f5556e5047f65e07596264a1e150eb0b750ee8f480ce0ee8f55e56ea1631e7a269ef6a0f2c5660b720f51702f20a189f84163e122d57b600e0736b3729189c21152297824a302f5d2a649f6f00b1f05c01d0e0b13822892ac05c0c06bd2a64578564655e38ebd5b650ee607e164febf432163e4a89f00b8d765ec6bf4e5f39a6a1625b9549ffae4e91fbf4965a156097d9c56b59865c72d79f6739c12ae0659d02006a3d55bc52540320e2a8aeae3e145ba40ce14269f61dd59211863d06492a86e39bbaab4d61c2e57f0a35290de73aa14f8b0a946f433e36c2a9608a127247c68d3b187a39387df7b40ad43da4b7fdb322a032a7e4b99df77d131f502f8acf30d90595cbc40654acaab81803aa461c179bb93c7fe7d41431ed71f47d594906162205b73abb5c8aa9082a874adf8d5fa8b691d06c2c8af3a4548205c82c0903cc41558c008819aaa0f4604d13d7ab4881b4c74316a31511cedc7091c7154d344fb02e1665efa3707ce176c2a4925d57712aaad443a620ba1886844ac1d5f3b028d88785284bfdbee1893f978271acd66ed8601582e434d1375315fa6e73c03c1c334f14c194cf5e1cb3a356f1742e1496198b27847f15b87fc1bf984219f1f9f81282d8aba2df2bac4d9e3059085bb7ec3af22ad974aa13ef8144183cfd7bd958c003a17e2897fa0c8b47a2338828817d3dccaa5580de301e65ce49dc7e808535ad94939fc4580be54a941413e11526e4e6a875218c772f27a7218b523f9388152755e97c927a2a46bd8eeef6932a83d295f06eb8b546fc8018f33d3c8988cd8a07c87b86ed49e6baeffdc9cf7d35902a4abdc229b24c9ad34c12851e80d15fb3604b2f2aad359acfd08cb2a8e3215e4b37d716a763e9641f2a6c561842611e5f4c103522ace2a8559c7db7b52ec19e5489e4578959f19be45e56c974a5f1bfcf63abb2f5d12ef6aead35fefafe3797bf3e9dfc393e9d3cf253dc80f3512f346a2d36eebecf19dabf60423ea9fae78162a492ff8b7647339ad3dc5edfdedefe17ccfa0f41', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138817, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f45528b4c800002f790520', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138818, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230c94dd7cf4e57f00cd3f7f455283432c900004b970668', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138819, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f45528b4c800002f790520', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138820, 862, 6.5, 6.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230d333cd4dd7cf4e57f00cd3f7f455283432c9000055de06cd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138821, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f405001d1203ef', X'789ced5a5b53db4816fe2ba778d825157c07c278b35365c88d4a202e9c64b21553aeb6d4963b48dddaee9613ed14ff7dbf966c631b19196576f330f39002a9fb7ce77e13f97dcfd74930922ce27b5dda7bcda56591f084dc3ba0bd4487eee5d4dad8741b8d6fe2864775a503f79b68acdf359e6631f747cc3a9276b37d5c6bb66aade687e6b3ee51a77bf4acde69b73b479dec2ef7ac50d2e0e6ef8e25d72ccc7eb7fc7b46fe218d7977287b91902a08534f19e1f3a17ca10c0b38bd523a325d3abff8079d7f1aca3315454ad207cd7c4e975004674e36e1a5f2805e33cda214421e642fd94d2640325e95e116af2c1b87dc3d7db9c65328e44df67027d3ba30e5e6d9b87f7bedb8f4fc24b423e82164b0a6712f0ca1d184d4981b7e4089e1d4f3bf26c6729f7ee322985afa279d9ffe464fa9593fa4efb4dfc343cdbd7a024339eafc3e691e7366c9cf78d0981920c03c219ff1d01428bf70c0a8bd26d0cbef964b1fb4e7d2723d63e1501ed59e4541e32680d5e9dfedc3e950be121a1ca10eefd2caa9f3899c391728e9081107f5c5e145c3519f4cf7d66dee8cf3517a2a8a43e131683d7aada4f294e76d8446fbb019391898a0558031809a9a8ffae72fd6a85af5a30dfe4339b04c5b6aafbe07a633a6ed52a7b64e90a97b2e270ab125669cbe098b171ee2c4cfc36b53969d626a83fee1803a5bb99c47d3cff3dc660cfde5ba47baae92c136adfea7b2d84f55b64ac3f8417dfbdc17cc6ae16d6d17ec070bfefef393d10b969ad1fbd07fb2067f571d28e3d45e1af953c385236cf9bc7d42df38bf3114706399431fca8d7bb96d33abafbf3f745e6a9fd4dabf9463b44e1ec0e8346b9dceee18d482ffefcba8f3c376970e370e3bc7b59ccfe11fc964e3a8d639762c8ef0b39c0bb5da0fb12961f22a0943fac07554207e7b61e74dd2a25ebd8ca17908d546add1859276faf840ea341f13045b8cb7631c6cd57147176fa1cfc4dbd1815b34c9a033f7d842f76c35c083de993b65543bce7f31ebeed9cae4f87efc3ec4e6d75de0efa06bcf8aeac44704899b70c5847e6da7ea113d26ef0f31f70484e9ab3809d95db55b08d3d73c904c7a295de1540643d9a51743f98e79b9a7bad4d76a0c06291936c1b671c53102515e7c21bb9bdcd7c72312f3016b5e7b71aacf426a356b47cd2e05ae99c0ad7901c94e9eb796ef0f4f6acf9cc7dff048a1ce87a911667eb63273b10918d0e27c2897a35d316764c1313808e9698e36b06809cbcb1bbd61215507346ca684efd68ea15c369e9db4ed6cd3b6eb0cd1fe65de559122b5cccbbb18a211732dac92dc315b374efb271ae60d8f1129de3c24b081b990a0bfd1d260d8c42e153a319f08c9fdaa73c366a0960f0f2fdc0a9f5f362321474b84f92801375acd3060b871f35e62a030731da46415792133a6e1be083c4ef8f96e8b01cdf0d11567de7d2ec5f3ab162a59bff7de2aabbe0b4fd87428bfb4ae61521e4ff5ca4ba469a8649069426a4292275a4589f190f69ac6a1f26e204741b9ca3f14ac71bb64f02c6bcc5424f29a70ae11793934662a21bfe6f29211963fba22fd8fd5db34e7ff5bbf3f82df2363ac3f653a621e2c14a46b8cdfb070520bc58477dbb50e4d55a291c5171c582a1426eaba1281e4cf0bfd478dfc24be78e12e7a532671cf19bce7e5b74e9130c66545a73920267d3ac24f2dc6caa8083503922752587380326474123b7d29babaec11724d9a70aeb49cd7a409820117dc768172e3e10d8a17c5f03c1730478aeec9b352f6a57d5d25f950a5c742a13c8d065cc2ba62867fbc3c07dff275430e86d220d838f401b786998371da4f4cc2c23045913b1fca4ca7282b7c389a31689375ce1552edf4b14c5a505c0de5f291f69526893ac927132709b0ddaa84da94a30f9e428414934580fb28b799c93c8ec9e81b6ec0a20b4d61ac8fb8ba947002dc8f1fce51c721c9be7451961acb23600839c99506fe670c9d5291cf2cc3437b28592e04dc009b697540e3c4660226ae2bdcc986db9d076edf5d5cd1ccc9f45aab24a61e198b558d6284702a03886c08874bc90cf90977e1f6b24e13c601e4a2e1f361158e734e281d4850c11e4e6cb49e4cc2ecfbaf6611f5556e5047f65e07596264a1e150eb0b750ee8f480ce0ee8f55e56ea1631e7a269ef6a0f2c5660b720f51702f20a189f84163e122d57b600e0736b3729189c21152297824a302f5d2a649f6f00b1f05c01d0e0b13822892ac05c0c06bd2a64578564655e38ebd5b650ee607e164febf432163e4a89f00b8d765ec6bf4e5f39a6a1625b9549ffae4e91fbf4965a156097d9c56b59865c72d79f6739c12ae0659d02006a3d55bc52540320e2a8aeae3e145ba40ce14269f61dd59211863d06492a86e39bbaab4d61c2e57f0a35290de73aa14f8b0a946f433e36c2a9608a127247c68d3b187a39387df7b40ad43da4b7fdb322a032a7e4b99df77d131f502f8acf30d90595cbc40654acaab81803aa461c179bb93c7fe7d41431ed71f47d594906162205b73abb5c8aa9082a874adf8d5fa8b691d06c2c8af3a4548205c82c0903cc41558c008819aaa0f4604d13d7ab4881b4c74316a31511cedc7091c7154d344fb02e1665efa3707ce176c2a4925d57712aaad443a620ba1886844ac1d5f3b028d88785284bfdbee1893f978271acd66ed8601582e434d1375315fa6e73c03c1c334f14c194cf5e1cb3a356f1742e1496198b27847f15b87fc1bf984219f1f9f81282d8aba2df2bac4d9e3059085bb7ec3af22ad974aa13ef8144183cfd7bd958c003a17e2897fa0c8b47a2338828817d3dccaa5580de301e65ce49dc7e808535ad94939fc4580be54a941413e11526e4e6a875218c772f27a7218b523f9388152755e97c927a2a46bd8eeef6932a83d295f06eb8b546fc8018f33d3c8988cd8a07c87b86ed49e6baeffdc9cf7d35902a4abdc229b24c9ad34c12851e80d15fb3604b2f2aad359acfd08cb2a8e3215e4b37d716a763e9641f2a6c561842611e5f4c103522ace2a8559c7db7b52ec19e5489e4578959f19be45e56c974a5f1bfcf63abb2f5d12ef6aead35fefafe3797bf3e9dfc393e9d3cf253dc80f3512f346a2d36eebecf19dabf60423ea9fae78162a492ff8b7647339ad3dc5edfdedefe17ccfa0f41', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138822, 862, 6.5, 7.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230d333d535d733cd4dd7cf4e57f00cd3f7f455283432c900006c8c0794', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138823, 2323, 200.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c333230d0353130c84d5708f057283434ca0000234b0443', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138824, 2323, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789c333630c84d5708f057283434ca50a850304f01002ce304d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138825, 2323, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789c333630c84d5708f057283434ca50a850304f01002ce304d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138826, 2323, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789c333630c84d5708f057283434ca50a850303448010031a30500', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138827, 2323, 400.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c333130c84d5708f057283434ca50a85030d735344901003bfd0569', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138828, 2323, 400.0, 400.0, 'mg', 'PO', 2, 'Pediatric', X'789cb33334aa2c2ab652303130c84d5708f05770f27451a8503034490100603006f1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138829, 2323, 20.0, 20.0, 'mg/kg', NULL, 2, 'Pediatric', X'789c3332c84dd7cf4e5770f27451a850303448d151c84dac5030310089a7e417a702009b540998', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138830, 353, 5.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789c33d53534c84d5708f057287449cccca90400241c04db', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138831, 353, 5.0, 5.0, 'mg', 'PO', NULL, 'Adult', X'789c0dca310a80300c05d0abfc038843a18bb3bb82270834d5406c3546a1b7b7d35bdee6643e219e3bd605f74ca20db91aa4b890823a47bbd89c9f221f0f4815618c900cd6c4d67bdfa124a81446b277ff01da6d1d42', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138832, 353, 2.5, 5.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33d233d535cd4d5708f057287449cccca904002780050f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138833, 260, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652704e2c503035c84dd7513037cd4db756700d020b191900c5001c130c7a', X'789ced5a5b6fda4814fe2b47482bed4ad09064d3566c5f68689b6c9b340af469a9acc13ee051c633de9931c1adf2dff7cc9818ecb0c549bbbd2d2f09b6cffd7ce7e2818fad4867b340b2045b3d68bd46ab52ada6285b6d68655ab89bb1b5a9e9eded5df32b4c1e293d739ff85e95d6849aa51805cc3a9683eec1e34e77bfb3df1d759ff48e1ef7badd47874787ddc3034f8ba1e54a1aa2fcd8ea470997dc58cddc3d7fcbe2c24b19e529f6c6f27cd83f1d8ce54019364378a974627a70cc5238ea26b3363c394a667fc08b4b7feba04bf7c6f25265160da82954c5f7e0ad66622c8f5592280923cd22847372deb827d99c71e10dcc26eb36ded02dcb2602ddd55fefe94a7079e52f56c67a2bb747ad20bb79ef64f6a34cd880fce27256717c830dad0bc6653b48b8883a898a90fcc10a8f0b065cbc85bf1f779ec66379c6163d3874d1d88b58deaa7ae094bf351615d336d6dc725311e522ea448d4e07a034949279e42e7d885dbce9564401cb1b28bb8c314b98559c00f295540e7293a0545ac7c83e2b507d697987cba960897341e74166d0d44412d2bb2b0f164f3afbbf93a5b9d926ff13d0f2ca3f3beb7518edd2fe23a4fdbfcd521d13bb343d304d5f2370f564fd1c917bb817f5787c5337beb8f2e69b47311e30e2cc6a1e6eda22ca8760d8146d0e53c29c8db901b7f341cc0c486521470b134409689c2a6e628c1e60ca30c59033115ca834136c959f4fee341a6792c9300f2e89a366fe31cb1c25b068ce0d46c025ec1b0be410ad6b16b577477373e5d63c4c263a571d729309b06ac1436ea99cfa73aa4da09c00f9a69d0a6096220ed7573073fe7a0deb82528d94c94c2314b2a22cb499016246cd95a18fa1a07f1a6989bc6be0949805426a0dd9993b755641a864887c8e1b6af00d0b0b1b02a7bfea3e0589d3c4072648b524aa39c275cc49fc442333768a945f8ad986b18b9212b101117ee1a48dfa8cf609384d52c63555a1ed010111f68fba5000915cd3c7029e1d1c2d9f74574f4e067b17831e9c2b30599a0a74fc635942cd3db110e194cb024535d34e30254f36c2b530aea610aeb98d212eb88097263755b9b580fe7708acd7e00e82df18825f28017796ba5d061aaf71df51a8ea69fcde62f535ecb9e7e641556235bd27473cdcb077f485403dcb7d1b14cc983db7fc505f1ef6c7b47f96a74bb4c551a3c5682ca9ace284150f33ead821d39c2ecb49516be4eb7d9c80d07ffe8a32ad67a873485dc34e5df3277d26e59afa3339cceee9e49a2fc3fef613264744d21e7a32b5ce5984a281ca82aec25b866e3bfbbb92f4f65c6c8eda6070892c6cb6480e5da4b32addab53a070fafed876a9a019eb93d4864c8448c93d3b1dcbf6580ead5657e83f9e8ccefdffe3939763398ab54a268ae6baa2a538194bdf262065291782517a25869aaac0b4e9534ac4b743bf5dc05dad9680e79a0670ac4cca9c9ca1c5394ad3f953c5d2d0f436b98c485561c2c83101a6aeedd3242f94889cd4108624260e8a6d724ca908a2dc9dba1acec88494a8949cd11270eb3458ee649ee4e4fb15ed0449918a5a2f2e4e422b81a377b31453e3358da564845faf944d2295f02206dc619da26f79ba44fe09b2888571e145c43f7ca06a36c6f1199548259056108a2133b1bbe74a238d5193308c686569c35464b42869b4d41cbcc0119792d3e6e3c9638aa6a1a0d11bf6dc87f44518c679a27c5c0628584e9eabf9f2cde31e4d6de5f6d9e976a4124d05e40576b6f32de92abc04b6ed8c8ea8c245d0dccee5886a766e865c13cb2b9c41c95991ffefa8ddaec1f306256fb0c65bd151a0bf41332ae8aab1ae15c196a0af5357e494a5b15dc88ab422a128a706ddb8a0abe67eade01a80609dba1a8d65a93688c42d6585bfacee065128492b125c1bd8ceeca9aa385bf68406a8baa52c46ca6e40341e10f5d9ba9b10bb09b19b10bb09f1934f889fb6cd3de4457387e21f14c51731a31619d2a89fe5152c9f3031ed083ec51e1c3cda77dfac21a1c02f2e3d78c3e9851b88d2016b8e823614cb8dc99030f562111216fd6f67de6972119e767f815f9fedd3df8c7616e6568adf1e706a73868e99d4076a1af4c33b3ffe3995319f706b20cc435a6616f98cb62b836daa8c280bddfa421b8db16c2618559904fa0bb6d8c8168ccca43164635cce97fb7e978518f485511583fcf988591e189527fc9ff573a106f95dd2dd3dd0a958d0404650d213526e6efe01a1fcbda1', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138834, 260, 50.0, 50.0, 'mg', 'PO', NULL, 'Adult', X'789c3335c84d5708f0572834d3b5c8000018a8038d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138835, 260, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303630c84dd74f49ac04001ede0455', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138836, 260, 75.0, 75.0, 'mg', 'PO', 1, 'Adult', X'789c3337cd4d5708f05708f17451c82f52303580700b3353405c230310df350824949298995309003c6b0da8', X'789ced5a5b6fda4814fe2b47482bed4ad09064d3566c5f68689b6c9b340af469a9acc13ee051c633de9931c1adf2dff7cc9818ecb0c549bbbd2d2f09b6cffd7ce7e2818fad4867b340b2045b3d68bd46ab52ada6285b6d68655ab89bb1b5a9e9eded5df32b4c1e293d739ff85e95d6849aa51805cc3a9683eec1e34e77bfb3df1d759ff48e1ef7badd47874787ddc3034f8ba1e54a1aa2fcd8ea470997dc58cddc3d7fcbe2c24b19e529f6c6f27cd83f1d8ce54019364378a974627a70cc5238ea26b3363c394a667fc08b4b7feba04bf7c6f25265160da82954c5f7e0ad66622c8f5592280923cd22847372deb827d99c71e10dcc26eb36ded02dcb2602ddd55fefe94a7079e52f56c67a2bb747ad20bb79ef64f6a34cd880fce27256717c830dad0bc6653b48b8883a898a90fcc10a8f0b065cbc85bf1f779ec66379c6163d3874d1d88b58deaa7ae094bf351615d336d6dc725311e522ea448d4e07a034949279e42e7d885dbce9564401cb1b28bb8c314b98559c00f295540e7293a0545ac7c83e2b507d697987cba960897341e74166d0d44412d2bb2b0f164f3afbbf93a5b9d926ff13d0f2ca3f3beb7518edd2fe23a4fdbfcd521d13bb343d304d5f2370f564fd1c917bb817f5787c5337beb8f2e69b47311e30e2cc6a1e6eda22ca8760d8146d0e53c29c8db901b7f341cc0c486521470b134409689c2a6e628c1e60ca30c59033115ca834136c959f4fee341a6792c9300f2e89a366fe31cb1c25b068ce0d46c025ec1b0be410ad6b16b577477373e5d63c4c263a571d729309b06ac1436ea99cfa73aa4da09c00f9a69d0a6096220ed7573073fe7a0deb82528d94c94c2314b2a22cb499016246cd95a18fa1a07f1a6989bc6be0949805426a0dd9993b755641a864887c8e1b6af00d0b0b1b02a7bfea3e0589d3c4072648b524aa39c275cc49fc442333768a945f8ad986b18b9212b101117ee1a48dfa8cf609384d52c63555a1ed010111f68fba5000915cd3c7029e1d1c2d9f74574f4e067b17831e9c2b30599a0a74fc635942cd3db110e194cb024535d34e30254f36c2b530aea610aeb98d212eb88097263755b9b580fe7708acd7e00e82df18825f28017796ba5d061aaf71df51a8ea69fcde62f535ecb9e7e641556235bd27473cdcb077f485403dcb7d1b14cc983db7fc505f1ef6c7b47f96a74bb4c551a3c5682ca9ace284150f33ead821d39c2ecb49516be4eb7d9c80d07ffe8a32ad67a873485dc34e5df3277d26e59afa3339cceee9e49a2fc3fef613264744d21e7a32b5ce5984a281ca82aec25b866e3bfbbb92f4f65c6c8eda6070892c6cb6480e5da4b32addab53a070fafed876a9a019eb93d4864c8448c93d3b1dcbf6580ead5657e83f9e8ccefdffe3939763398ab54a268ae6baa2a538194bdf262065291782517a25869aaac0b4e9534ac4b743bf5dc05dad9680e79a0670ac4cca9c9ca1c5394ad3f953c5d2d0f436b98c485561c2c83101a6aeedd3242f94889cd4108624260e8a6d724ca908a2dc9dba1acec88494a8949cd11270eb3458ee649ee4e4fb15ed0449918a5a2f2e4e422b81a377b31453e3358da564845faf944d2295f02206dc619da26f79ba44fe09b2888571e145c43f7ca06a36c6f1199548259056108a2133b1bbe74a238d5193308c686569c35464b42869b4d41cbcc0119792d3e6e3c9638aa6a1a0d11bf6dc87f44518c679a27c5c0628584e9eabf9f2cde31e4d6de5f6d9e976a4124d05e40576b6f32de92abc04b6ed8c8ea8c245d0dccee5886a766e865c13cb2b9c41c95991ffefa8ddaec1f306256fb0c65bd151a0bf41332ae8aab1ae15c196a0af5357e494a5b15dc88ab422a128a706ddb8a0abe67eade01a80609dba1a8d65a93688c42d6585bfacee065128492b125c1bd8ceeca9aa385bf68406a8baa52c46ca6e40341e10f5d9ba9b10bb09b19b10bb09f1934f889fb6cd3de4457387e21f14c51731a31619d2a89fe5152c9f3031ed083ec51e1c3cda77dfac21a1c02f2e3d78c3e9851b88d2016b8e823614cb8dc99030f562111216fd6f67de6972119e767f815f9fedd3df8c7616e6568adf1e706a73868e99d4076a1af4c33b3ffe3995319f706b20cc435a6616f98cb62b836daa8c280bddfa421b8db16c2618559904fa0bb6d8c8168ccca43164635cce97fb7e978518f485511583fcf988591e189527fc9ff573a106f95dd2dd3dd0a958d0404650d213526e6efe01a1fcbda1', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138837, 260, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303630c84dd74f49ac04001ede0455', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138838, 260, 75.0, 75.0, 'mg', 'PO', 1, 'Adult', X'789c3337cd4d5708f05708f17451c82f52303580700b3353405c230310df350824949298995309003c6b0da8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138839, 260, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303630c84dd74f49ac04001ede0455', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138840, 260, 50.0, 50.0, 'mg', 'PO', NULL, 'Adult', X'789c3335c84d5708f0572834d3b5c8000018a8038d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138841, 260, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303630c84dd74f49ac04001ede0455', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138842, 260, 50.0, 100.0, 'mg', 'PO', 3, 'Adult', X'789c3335d0353430c84d5708f05708f17451a830d73534514849ac2c0600558f06ea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138843, 260, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303630c84dd74f49ac04001ede0455', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138844, 260, 150.0, 150.0, 'mg', NULL, NULL, 'Adult', X'789cf3cdcc4951f0cc2d48cc2cca4dcd2bb152f04dac5030343550c84dd74f49ac0400aae30a54', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138845, 260, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c732e72ce51b03132b552f04dac5030343050c84dd74f49ac0400508a06ba', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138846, 260, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c734c29cd29b152f04dac5030343050c84dd74f49ac5428cf2cc950c8482d482cc94c56c8cc2d48cc2cca4dcd2b010053e60fbd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);